SCHEMBL992989

SCHEMBL992989

NC(=O)CNCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Monoethanolamine SCHEMBL28084893 0.93 MAOA (0.59)
Urea SCHEMBL28111873 0.89 MAOA (0.55)
SCHEMBL8447495 0.89 MAOA (0.50)
SCHEMBL5233047 0.85 MAOA (0.61)
SCHEMBL7621771 0.85 MAOA (0.47)
SCHEMBL28866669 0.84
SCHEMBL4780532 0.82 MAOA (0.40)
Diethanolamine SCHEMBL27879356 0.80 ALDH1A1 (0.35)
SCHEMBL5930720 0.79
Diethanolamine SCHEMBL8571462 0.79 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353821-A1 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS INST NAT SANTE RECH MED (FR) 2025-11-20 US claimed
CN-119798223-A (1H-indazol-5-yl) amino-2-pyridine derivative and application thereof 沈阳药科大学 2025-04-11 CN claimed
EP-4452956-A1 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2024-10-30 EP claimed
CN-118574812-A Benzenesulfonamide thiazole compounds and their use for the treatment of cancer 国家医疗保健研究所 2024-08-30 CN claimed
WO-2023118373-A1 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2023-06-29 WO claimed
EP-4201928-A1 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2023-06-28 EP claimed
US-20170166523-A9 MEK Inhibitors And Methods Of Their Use EXELIXIS, INC. 2017-06-15 US claimed
US-20150315142-A1 PROCESS TO OBTAIN IMIDAZOLINE MIXTURES FROM VEGETABLE OILS CORROSION Y PROTECCION SA DE CV (MX) 2015-11-05 US claimed
US-20150141399-A1 MEK Inhibitors And Methods Of Their Use EXELIXIS INC (US) 2015-05-21 US claimed
EP-2454257-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES Abbott Laboratories (US) 2012-05-23 EP claimed
US-20090012126-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2009-01-08 US claimed
US-20080139575-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2008-06-12 US claimed
US-20080132545-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2008-06-05 US claimed
WO-2008016643-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
CN-1980661-A Cationic bacteriochlorophyll derivatives and uses thereof YEDA RES & DEV (IL) 2007-06-13 CN claimed
US-7030216-B2 Peptoids incorporating chemoselective functionalities CHIRON CORPORATION (US) 2006-04-18 US claimed
US-20020169281-A1 Peptoids incorporating chemoselective functionalities CHIRON CORPORATION 2002-11-14 US claimed
WO-2002081637-A2 PEPTIDES INCORPORATING CHEMOSELECTIVE FUNCTIONALITIES CHIRON CORPORATION (US) 2002-10-17 WO claimed
EP-0567066-B1 Resin composition for aqueous paints KANSAI PAINT CO LTD (JP) 2000-07-12 EP claimed
EP-0591984-B1 Resin composition for aqueous paint KANSAI PAINT CO LTD (JP) 1997-07-09 EP claimed